--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About NVO20260327P35
Pharmaceutical
Novo Nordisk A/S was established in 1989 by the merger of two Danish companies, Nordisk Gentofte A/S and Novo Industri A/S. The company is a global healthcare company and a world leader in obesity and diabetes care, manufacturing and marketing of pharmaceutical products including GLP-1 receptor agonists and modern insulins. Headquartered in Denmark, it operates in about 80 countries and sells its products in about 170 countries.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
